Concomitant differentiation and partial proteasome inhibition trigger apoptosis in neuroblastoma cells

Journal of Neuro-Oncology

Volumn 63, Issue 1, 2003, Pages 15-23

  Nahreini, Piruz ^a   Andreatta, Cynthia ^a   Hanson, Amy ^a   Prasad, Kedar N ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; Cell cycle; Differentiation; Neuroblastoma; Proteasome inhibition; Short lived EGFP

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE; CELL CYCLE PROTEIN; CYCLIC AMP; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; PROSTAGLANDIN A1; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; FLOW CYTOMETRY; GROWTH INHIBITION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; LEUPEPTINS; MICE; MULTIENZYME COMPLEXES; NEUROBLASTOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; RETROVIRIDAE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0038545241     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023713008809     Document Type: Article

References (35)

1. Ciechanover A, Orian A, Schwartz AL: Ubiquitin-mediated proteolysis: Biological regulation via destruction. Bioessays 22: 442-451, 2000
2. Ciechanover A, Schwartz AL: The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death. Proc Natl Acad Sci USA 95: 2727-2730, 1998
3. Schwartz AL, Ciechanover A: The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57-74, 1999
4. Koepp DM, Harper JW, Elledge SJ: How the cyclin became a cyclin: Regulated proteolysis in the cell cycle. Cell 97: 431-434, 1999
5. Harper JW: Protein destruction: Adapting roles for Cks proteins. Curr Biol 11: R431-R435, 2001
6. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ: Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Res 59: 2615-2622, 1999
7. Niedermann G: Immunological functions of the proteasome. Curr Top Microbiol Immunol 268: 91-136, 2002
8. Krek W: Proteolysis and the G1-S transition: The SCF connection. Curr Opin Genet Dev 8: 36-42, 1998
9. Shimbara N, Orino E, Sone S, Ogura T, Takashina M, Shono M, Tamura T, Yasuda H, Tanaka K, Ichihara A: Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. J Biol Chem 267: 18100-18109, 1992
10. Feikova S, Wolff L, Bies J: Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells. Neoplasma 47: 212-218, 2000
11. Prince AM, May JS, Burton GR, Lyle RE, McGehee RE Jr: Proteasomal degradation of retinoblastoma-related p130 during adipocyte differentiation. Biochem Biophys Res Commun 290: 1066-1071, 2002
12. Borriello A, Pietra VD, Criscuolo M, Oliva A, Tonini GP, Iolascon A, Zappia V, Ragione FD: p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: Evidence of a decreased proteasome-dependent degradation. Oncogene 19: 51-60, 2000
13. Wojcik C, Wilk S: Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells. Neurochem Int 34: 131-136, 1999
14. Kim SS, Rhee S, Lee KH, Kim JH, Kim HS, Kang MS, Chung CH: Inhibitors of the proteasome block the myogenic differentiation of rat L6 myoblasts. FEBS Lett 433: 47-50, 1998
15. Miyake S, Sellers WR, Safran M, Li X, Zhao W, Grossman SR, Gan J, DeCaprio JA, Adams PD, Kaelin WG Jr: Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol Cell Biol 20: 8889-8902, 2000
16. Nahreini P, Andreatta C, Prasad KN: Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells. Cell Mol Neurobiol 21: 509-521, 2001
17. Kain SR: Green fluorescent protein (GFP): Applications in cell-based assays for drug discovery. Drug Discov Today 4: 304-312, 1999
18. Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG: Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol 18: 538-543, 2000
19. Prasad KN: Differentiation of neuroblastoma cells: A useful model for neurobiology and cancer. Biol Rev 66: 431-451, 1991
20. Andreatta C, Nahreini P, Hovland AR, Kumar B, Edwards-Prasad J, Prasad KN: Use of short-lived green fluorescent protein for the detection of proteasome inhibition. Biotechniques 30: 656-660, 2001
21. Nahreini P, Hovland AR, Kumar B, Andreatta C, Edwards-Prasad J, Prasad KN: Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell Mol Neurobiol 21: 65-79, 2000
22. Lee DH, Goldberg AL: Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8: 397-403, 1998
23. Hovland AR, Nahreini P, Andreatta CP, Edwards-Prasad J, Prasad KN: Identifying genes involved in regulating differentiation of neuroblastoma cells. J Neurosci Res 64: 302-310, 2001
24. Lundberg AS, Weinberg RA: Control of the cell cycle and apoptosis. Eur J Cancer 35: 1886-1894, 1999
25. Prives C, Hall PA: The p53 pathway. J Pathol 187: 112-126, 1999
26. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000
27. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994
28. Herceg Z, Wang ZQ: Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res 477: 97-110, 2001
29. Bromme HJ, Holtz J: Apoptosis in the heart: When and why? Mol Cell Biochem 163-164: 261-275, 1996
30. Nakayama KI, Hatakeyama S, Nakayama K: Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun 282: 853-860, 2001
31. Shen L, Tsuchida R, Miyauchi J, Saeki M, Homa T, Tsunematsu Y, Kato J, Mizutani S: Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma. Int J Oncol 17: 749-754, 2000
32. McDonald ER 3rd, El-Deiry WS: Checkpoint genes in cancer. Ann Med 33: 113-122, 2001
33. Yew PR: Ubiquitin-mediated proteolysis of vertebrate G1-and S-phase regulators. J Cell Physiol 187: 1-10, 2001
34. Desdouets C, Sobczak-Thepot J, Murphy M, Brechot C: Cyclin A: Function and expression during cell proliferation. Prog Cell Cycle Res 1: 115-123, 1995
35. Hashida T, Todo S, Imashuku S: Role of adenosine 3′5′-cyclic monophosphate in antineoplastic effect of prostaglandins (PGE1, PGE2, PGD2 and PGA1) on human neuroblastoma cells. Prostaglandins Leukot Essent Fatty Acids 33: 61-68, 1988